Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies
Publication
, Journal Article
Prasad, VK; Chen, D-F; Broadwater, G; Reinsmoen, NL; Clark, A; Chao, NJ; Rizzieri, DA
Published in: BLOOD
November 16, 2008
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
1118 / 1118
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Prasad, V. K., Chen, D.-F., Broadwater, G., Reinsmoen, N. L., Clark, A., Chao, N. J., & Rizzieri, D. A. (2008). Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies. BLOOD, 112(11), 1118–1118.
Prasad, Vinod K., Dong-Feng Chen, Gloria Broadwater, Nancy L. Reinsmoen, Adella Clark, Nelson J. Chao, and David A. Rizzieri. “Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies.” BLOOD 112, no. 11 (November 16, 2008): 1118–1118.
Prasad VK, Chen D-F, Broadwater G, Reinsmoen NL, Clark A, Chao NJ, et al. Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies. BLOOD. 2008 Nov 16;112(11):1118–1118.
Prasad, Vinod K., et al. “Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies.” BLOOD, vol. 112, no. 11, AMER SOC HEMATOLOGY, Nov. 2008, pp. 1118–1118.
Prasad VK, Chen D-F, Broadwater G, Reinsmoen NL, Clark A, Chao NJ, Rizzieri DA. Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies. BLOOD. AMER SOC HEMATOLOGY; 2008 Nov 16;112(11):1118–1118.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
1118 / 1118
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology